Treating Coagulation Disorders Without Bleeding Side Effects
Treating Coagulation Disorders Without Bleeding Side Effects
Embedded Files
SLU ID 16-004 | Thrombin-Thrombomodulin Fusion Proteins as Anticoagulants
SLU ID 16-004 | Thrombin-Thrombomodulin Fusion Proteins as Anticoagulants
Intellectual Property Status
Intellectual Property Status
Seeking
Seeking
Patented
Know-how based
Licensee
Development partner
Commercial partner
Investment
University spin out
Background
Background
Congenital or acquired Protein C and thrombomodulin mutations and deficiencies are established risk factors of thrombosis.
Overview
Overview
Researchers at Saint Louis University have developed a method to turn thrombin into a potent anticoagulant.
Benefits
Benefits
The potential benefits of this technology include:
Minimizing the cost of anticoagulants
Minimizing the adverse effects of anticoagulants
Applications
Applications
The potential applications of this technology include:
Anticoagulants
Antiseptic agents
Detection and quantification of protein C/FV Leiden genetic mutations
Opportunity
Opportunity
Saint Louis University is seeking a partner to further develop and commercialize this technology.
Report abuse